Pancreatic Cancer Research

ResearcherUniversity of IowaNo recent work listed

Douglas Robert Spitz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1254-8765; OpenAlex author ID A5044316011; NIH RePORTER profile ID 1891156. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
2
Labs led
1
Collaborators
19
Papers, trials and grants by year

2011: 1 paper · 2012: 1 grant · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 grant

Papers 5

  1. Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-18-1680↗
  2. Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience… Co-author DOI 10.1667/rr14668.1↗
  3. Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-14-1707↗
  4. Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-14-1959↗
  5. Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance. First author DOI 10.1016/j.freeradbiomed.2011.03.030↗

Grants 2

  1. Project 1: Inhibition of Metastasis Utilizing Pharmacological Ascorbate in Pancreas Cancer P01CA217797↗
  2. Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial R21CA161182↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph J. Cullen · 3 shared papers, 1 shared grant, 2011–2022 · strength 0.81
  2. Daniel Berg · 2 shared papers, 1 shared grant, 2012–2018 · strength 0.22
  3. John Michael Buatti · 2 shared papers, 1 shared grant, 2012–2018 · strength 0.22
  4. Bryan G. Allen · 4 shared papers, 2015–2018 · strength 0.20
  5. Garry R. Buettner · 4 shared papers, 2011–2018 · strength 0.19
  6. Kellie L. Bodeker · 2 shared papers, 2017–2018 · strength 0.12
  7. Juan Du · 2 shared papers, 2015–2018 · strength 0.11
  8. Brianne R. O’Leary · 2 shared papers, 2015–2018 · strength 0.11
  9. James J. Mezhir · 2 shared papers, 2015 · strength 0.08
  10. Matthew S. Alexander · 1 shared paper, 2018 · strength 0.07
  11. Justin G. Wilkes · 1 shared paper, 2018 · strength 0.07
  12. Amir Zahra · 1 shared paper, 2017 · strength 0.05
  13. Jessemae L. Welsh · 1 shared paper, 2015 · strength 0.04
  14. Prabhat C. Goswami · 1 shared paper, 2015 · strength 0.04
  15. John A. Cieslak · 1 shared paper, 2015 · strength 0.04
  16. Zita A. Sibenaller · 1 shared paper, 2015 · strength 0.04
  17. Susan Tsai · 1 shared paper, 2015 · strength 0.04
  18. Wendy Cozen · 1 shared paper, 2015 · strength 0.04
  19. Charles F. Lynch · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.